Our Services

Specialist Advisory Services

Pharmaceutical Strategy & Portfolio Advisory

Board-level strategic direction for products and portfolios — positioning, licensing routes, indication and lifecycle planning, and market-entry readiness. We turn complex options into one clear, commercially viable plan.

Medical Affairs & Scientific Advisory

Senior medical affairs and scientific advisory — evidence review and literature appraisal, medical strategy, scientific positioning, medical writing and HCP-facing materials — aligning your clinical credibility with regulatory, medical and commercial objectives.

Regulatory Affairs & Lifecycle Management

End-to-end regulatory affairs across UK, EU, Gulf and international pathways — submissions, variations, renewals, SmPC/PIL and product information — keeping your portfolio compliant, current and commercially relevant. Post-Brexit UK licensing a speciality.

Product Development, CMC & Technical Dossier Support

Technical and CMC advisory from formulation to filing — quality documentation, manufacturing considerations, stability, Module 3 readiness and dossier planning — connecting product-design decisions to regulatory and launch requirements.

Medical Information & Scientific Communications

A compliant medical information service — accurate, balanced responses to HCP, patient and carer enquiries, standard response documents, enquiry triage and PV interfacing — protecting both your brand and your patients.

Pharmacovigilance, RMPs & Safety Governance

Pharmacovigilance built to inspection-ready standard — PSMF, RMPs, ICSR and safety-escalation pathways, SOPs, training, CAPA and audit readiness — aligned to GVP and MHRA expectations.

Compliance, ABPI/PMCPA & Healthcare Governance

ABPI/PMCPA compliance and Final Medical Signatory support — MLR review, certification and examination of promotional and non-promotional materials, and SOP frameworks — keeping your communications compliant and defensible.

Market Access, Category Switch & Commercial Strategy

UK market access and commercial strategy — pricing and reimbursement, NHS listing, dm+d, Drug Tariff, formulary access and category switch — engineered for launch success and sustainable uptake.

Strategic Partnerships, Ventures & International Expansion

Bi-directional UK ↔ Gulf expansion and partnership advisory — market entry, local-partner strategy and investor-facing support across the UK, Saudi Arabia and the wider Gulf — from concept to commercial growth.